SE509694C2 - Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter - Google Patents

Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter

Info

Publication number
SE509694C2
SE509694C2 SE9102604A SE9102604A SE509694C2 SE 509694 C2 SE509694 C2 SE 509694C2 SE 9102604 A SE9102604 A SE 9102604A SE 9102604 A SE9102604 A SE 9102604A SE 509694 C2 SE509694 C2 SE 509694C2
Authority
SE
Sweden
Prior art keywords
composition according
methyl
bismuth
ranitidine
salt
Prior art date
Application number
SE9102604A
Other languages
English (en)
Swedish (sv)
Other versions
SE9102604L (sv
SE9102604D0 (sv
Inventor
Norman Richard Smith
Colin Roy Heppenstall
Stephen John Douglas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE9102604D0 publication Critical patent/SE9102604D0/xx
Publication of SE9102604L publication Critical patent/SE9102604L/xx
Publication of SE509694C2 publication Critical patent/SE509694C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
SE9102604A 1990-09-11 1991-09-10 Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter SE509694C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (fr) 1990-09-11 1992-03-05 Composition contenant un sel du type carboxylate de bismuth et de ranitidine

Publications (3)

Publication Number Publication Date
SE9102604D0 SE9102604D0 (sv) 1991-09-10
SE9102604L SE9102604L (sv) 1992-03-12
SE509694C2 true SE509694C2 (sv) 1999-02-22

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102604A SE509694C2 (sv) 1990-09-11 1991-09-10 Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter

Country Status (33)

Country Link
US (1) US5456925A (fr)
EP (1) EP0558779B1 (fr)
JP (1) JPH0692849A (fr)
KR (1) KR100196308B1 (fr)
AT (2) AT405134B (fr)
AU (2) AU640816B2 (fr)
BE (1) BE1005115A5 (fr)
BG (1) BG61931B1 (fr)
CA (1) CA2050970C (fr)
CH (1) CH683068A5 (fr)
CY (1) CY1988A (fr)
DE (2) DE4130061A1 (fr)
DK (1) DK159191A (fr)
ES (1) ES2072647T3 (fr)
FI (1) FI944047A7 (fr)
FR (1) FR2666508B1 (fr)
GB (2) GB9019875D0 (fr)
HK (1) HK60894A (fr)
HU (1) HU211846A9 (fr)
IE (1) IE65049B1 (fr)
IL (1) IL99428A (fr)
IT (1) IT1249696B (fr)
MX (1) MX9101009A (fr)
NL (1) NL194907C (fr)
NO (1) NO179694C (fr)
NZ (1) NZ239731A (fr)
OA (1) OA10093A (fr)
RO (1) RO112084B1 (fr)
RU (1) RU2108097C1 (fr)
SE (1) SE509694C2 (fr)
SK (1) SK279591B6 (fr)
WO (1) WO1993017679A1 (fr)
ZA (1) ZA917176B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
CA2211873A1 (fr) * 1995-01-26 1996-08-01 Michael Droege Composes de bismuth
RU2385155C2 (ru) * 1998-08-18 2010-03-27 Федеральное Государственное Унитарное Предприятие Государственный Научно-Исследовательский Институт "Биоэффект" (Фгуп Гнии "Биоэффект") Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения
EP1104673A1 (fr) * 1999-11-30 2001-06-06 Bayer Classics Composition pharmaceutique sans agent desintégrant contenant un bicarbonate
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
EP2309988B1 (fr) * 2008-07-21 2015-11-25 SI Group, Inc. Granulés d'ibuprofène sodique à teneur, leur préparation et leur utilisation dans la préparation de formes posologiques solides non effervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN115697354B (zh) * 2020-06-01 2024-11-08 香港大学 用于治疗sars-cov-2感染的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (fr) * 1988-07-18 1992-03-13 Glaxo Group Ltd
EP0363502B1 (fr) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Formulation liquide contenant du bismuth, procédé pour la préparer et son utilisation
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0692849A (ja) 1994-04-05
BE1005115A5 (fr) 1993-04-27
CA2050970C (fr) 2002-11-19
IT1249696B (it) 1995-03-09
KR100196308B1 (ko) 1999-06-15
OA10093A (en) 1996-12-18
ATA180191A (de) 1998-10-15
NL9101533A (nl) 1992-04-01
SK106094A3 (en) 1995-02-08
NZ239731A (en) 1993-10-26
DE4130061A1 (de) 1992-03-12
NL194907C (nl) 2003-07-04
AT405134B (de) 1999-05-25
RU2108097C1 (ru) 1998-04-10
CA2050970A1 (fr) 1992-03-12
BG99021A (bg) 1995-06-30
EP0558779A1 (fr) 1993-09-08
DK159191D0 (da) 1991-09-10
KR920005984A (ko) 1992-04-27
FI944047L (fi) 1994-09-02
ZA917176B (en) 1992-06-24
WO1993017679A1 (fr) 1993-09-16
CY1988A (en) 1997-09-05
GB2248185B (en) 1994-02-02
CH683068A5 (fr) 1994-01-14
DE69202696D1 (de) 1995-06-29
MX9101009A (es) 1992-05-04
GB9119284D0 (en) 1991-10-23
FR2666508B1 (fr) 1994-02-18
AU640816B2 (en) 1993-09-02
ES2072647T3 (es) 1995-07-16
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
NO179694C (no) 1996-12-04
RO112084B1 (ro) 1997-05-30
IE65049B1 (en) 1995-10-04
ITRM910673A1 (it) 1993-03-10
FR2666508A1 (fr) 1992-03-13
BG61931B1 (bg) 1998-10-30
IL99428A0 (en) 1992-08-18
SK279591B6 (sk) 1999-01-11
NO179694B (no) 1996-08-26
FI944047A0 (fi) 1994-09-02
NO920408D0 (no) 1992-01-30
HU211846A9 (en) 1995-12-28
AU8375791A (en) 1992-03-19
ITRM910673A0 (it) 1991-09-10
SE9102604D0 (sv) 1991-09-10
DK159191A (da) 1992-03-12
IE913191A1 (en) 1992-04-22
IL99428A (en) 1996-06-18
US5456925A (en) 1995-10-10
GB2248185A (en) 1992-04-01
FI944047A7 (fi) 1994-09-02
ATE122883T1 (de) 1995-06-15
GB9019875D0 (en) 1990-10-24
HK60894A (en) 1994-07-08
AU1334792A (en) 1993-10-05
EP0558779B1 (fr) 1995-05-24
NO920408L (no) 1993-08-02

Similar Documents

Publication Publication Date Title
SE509694C2 (sv) Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter
WO1999053918A1 (fr) Compositions stabilisees contenant des composes du type benzimidazole
JPH0399016A (ja) 二重被覆顆粒
CA1181695A (fr) Forme posologique de nitrofurantoine
CA2361843C (fr) Comprimes a avaler a teneur elevee en n-acetylcysteine
US3865935A (en) Tableting of erythromycin base
RU2197244C2 (ru) Фармацевтическая композиция и фармацевтический препарат, содержащие калиевую, натриевую и трис соли оксапрозина, их применение для устранения или уменьшения боли у млекопитающего и для лечения воспаления и нарушений, связанных с воспалением у млекопитающего, способ получения фармацевтического препарата
US3891755A (en) Dosage formulation for erythromycin cetyl sulfate
EP2117534B1 (fr) Composition pharmaceutique à principe actif atorvastatine
US5091191A (en) Pharmaceutical composition with improved dissolution property
JPH05262649A (ja) 医薬組成物
JPH1121236A (ja) ロキソプロフェン・ナトリウム固形製剤
JPWO2001089573A1 (ja) 製剤の安定化方法
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
HU217587B (hu) Ranitidint és bizmut-karboxilát-komplexet, valamint bázisos sókat tartalmazó gyógyászati készítmények
CZ209794A3 (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed